Login

Switch On Your HIV Smarts.

HIV remission: more clues, but still many questions

HIV remission: more clues, but still many questions

, by Liz Highleyman

Very early HIV treatment does not cure HIV, but can lead to HIV remission in some people, new studies presented at IAS 2017 show. Read More

Surprising price break for newly-approved hepatitis C drug

Surprising price break for newly-approved hepatitis C drug

, by Liz Highleyman

Two new hepatitis C cure drugs, Mavyret and Vosevi, have been approved by the FDA—offering a shorter course of treatment, for a lower cost. Read More

Long-acting antiretrovirals for HIV treatment and PrEP

Long-acting antiretrovirals for HIV treatment and PrEP

, by Liz Highleyman

At the recent IAS 2017 conference, we got good news about the safety and efficacy of a long-acting antiretroviral injection and a drug in a new class of medications. Read More

Gay men living with HIV factor being ‘undetectable’ into decisions about sex

Gay men living with HIV factor being ‘undetectable’ into decisions about sex

, by Emily Newman

People who are undetectable do not transmit HIV to others. Do people know this, and are they acting on it? Read More

Do you know U=U?

Do you know U=U?

, by Emily Newman

Advocates for “Undetectable=Untransmittable” (U=U) were out, proud and visible this year at the International AIDS Conference, spreading the message that people living with HIV with undetectable viral loads do not transmit HIV to partners. Read More